Frontiers in Medicine (Nov 2022)

Do worsening lung ultrasound scans identify severe COVID-19 trajectories?

  • Paul W. Blair,
  • Paul W. Blair,
  • Jimin Hwang,
  • Jackson Pearce,
  • Tiffany C. Fong,
  • Erjia Cui,
  • Phabiola Herrera,
  • Gigi Liu,
  • Ciprian Crainiceanu,
  • Trishul Siddharthan,
  • Trishul Siddharthan,
  • Danielle V. Clark,
  • The CCPSEI Research Team,
  • Katherine Fenstermacher,
  • Sophia Shea,
  • Stefanie Seo,
  • Josh Lawrence,
  • Lauren Sauer,
  • Bhakti Hansoti,
  • Richard Rothman

DOI
https://doi.org/10.3389/fmed.2022.1021929
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundWhile point-of-care ultrasound (POCUS) has been used to track worsening COVID-19 disease it is unclear if there are dynamic differences between severity trajectories.MethodsWe studied 12-lung zone protocol scans from 244 participants [with repeat scans obtained in 3 days (N = 114), 7 days (N = 53), and weekly (N = 9)] ≥ 18 years of age hospitalized for COVID-19 pneumonia. Differences in mean lung ultrasound (LUS) scores and percent of lung fields with A-lines over time were compared between peak severity levels (as defined by the WHO clinical progression scale) using linear mixed-effects models.ResultsMean LUS scores were elevated by 0.19 (p = 0.035) and A-lines were present in 14.7% fewer lung fields (p = 0.02) among those with ICU-level or fatal peak illness compared to less severe hospitalized illness, regardless of duration of illness. There were no differences between severity groups in the trajectories of mean LUS score 0.19 (p = 0.66) or percent A-lines (p = 0.40).DiscussionOur results do not support the use of serial LUS scans to monitor COVID-19 disease progression among hospitalized adults.

Keywords